the analysis of the treatment results of the co-operative therapy studies bfm 78 and 83 for the treatment of acute myelogenous leukemia in children revealed the following risk factors : death before the onset of therapy and early death occurred more frequently in children with acute monoblastic/monocytic leukemia and in children with initial wbc of greater than 100,000/microliters than in the other patient groups .
C0023467
acute myelogenous leukemia
C0023465
acute monoblastic/monocytic leukemia